A team out of New Zealand has discovered Ziehl-Neelsen positive bacteria in blood cells of dendritic cell and macrophage lineage. The importance of finding a Ziehl-Neelsen positive unidentified bacterial species inside circulating macrophages is under investigation. Logic suggests that therapies that enhance innate immunity, regulate immune signaling and control ineffective inflammation will restore immune efficacy so that a patient’s immune system can effectively handle a chronic intracellular microbial disease. Formulated EpiBro (or FepiBro) possesses the above qualities.
[button link=”http://thecrohnsinfection.org/dr-william-chamberlin-fepibro/” type=”big”] Read the Full Article[/button]
Inflammatory Bowel Disease (IBD) is a broad term that describes conditions with chronic or recurring immune response and inflammation of the gastrointestinal tract. The two most common inflammatory bowel diseases are ulcerative colitis and Crohn’s disease. In Crohn’s disease, inflammation can affect the entire digestive tract but is usually centered in the ileum (the final segment of the small intestine) and the beginning part of the colon (large intestine). Ulcerative colitis presents exclusively in the colon. Both illnesses are characterized by an abnormal response to the body’s immune system. They can occur at any age, but often initially develop in teenagers and young adults.